Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.
Almac Adds New Blistering Technology at US Facility
Friday, February 28, 2014
Simple solutions to bridge the gap between clinical and commercial packaging.
Sapio Sciences Announces Exemplar LIMS for Clinical and Research NGS Labs
Tuesday, February 25, 2014
Purpose-built system handles the sample tracking and processing needs of clinical or research laboratories
Irisbiosciences a New Player in 3D Cell Culture
Friday, February 14, 2014
Irisbiosciences is focused on the development, manufacturing and marketing of products for bio-/pharmaceutical research and development, namely 3D cell culture products, tissue models and human & stem cells for in-vitro experimentation.
Intelsius Enhances Patient Safety Products
Thursday, February 13, 2014
Company announces enhancement to ThermoTrek™ range of solutions.
GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases
Thursday, February 13, 2014
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.
Crown Bioscience to Showcase Novel “in life” Platforms for Oncology
Tuesday, February 11, 2014
Company will highlight its expertise in Oncology Drug Discovery at AACR 2014.
Fluxion Biosciences Expands IsoFlux Discovery Services Capabilities with Clinical Sample Procurement
Monday, February 10, 2014
New capability provides a full-service option for circulating tumor cell studies.
Nanotherapeutics Selects GE Healthcare Life Sciences Technologies
Thursday, February 06, 2014
FlexFactory™ biomanufacturing platform selected to perform a central role in NANO-ADM Center.
Showing Results 41 - 50 of 310
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Promising Drug for Parkinson's Disease
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson’s disease, scientists from the University of Sheffield have discovered.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,500+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!